On March 21, 2016, Echo Therapeutics, Inc. issued a promissory note to Platinum Partners Value Arbitrage Fund L.P. (Lender") in the aggregate principal amount of $150,000 in respect of a bridge loan made by such party. The promissory note, which bears interest at the prime rate, may, at Lender's option, be exchanged for securities issued in a subsequent financing by the Company, including the second tranche financing described in the filing with the SEC on February 3, 2016.
Echo Therapeutics, Inc.
Equities
ECTE
US27876L2060
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |